Regulation of NMDA receptor trafficking by amyloid-beta

Nat Neurosci. 2005 Aug;8(8):1051-8. doi: 10.1038/nn1503. Epub 2005 Jul 17.

Abstract

Amyloid-beta peptide is elevated in the brains of patients with Alzheimer disease and is believed to be causative in the disease process. Amyloid-beta reduces glutamatergic transmission and inhibits synaptic plasticity, although the underlying mechanisms are unknown. We found that application of amyloid-beta promoted endocytosis of NMDA receptors in cortical neurons. In addition, neurons from a genetic mouse model of Alzheimer disease expressed reduced amounts of surface NMDA receptors. Reducing amyloid-beta by treating neurons with a gamma-secretase inhibitor restored surface expression of NMDA receptors. Consistent with these data, amyloid-beta application produced a rapid and persistent depression of NMDA-evoked currents in cortical neurons. Amyloid-beta-dependent endocytosis of NMDA receptors required the alpha-7 nicotinic receptor, protein phosphatase 2B (PP2B) and the tyrosine phosphatase STEP. Dephosphorylation of the NMDA receptor subunit NR2B at Tyr1472 correlated with receptor endocytosis. These data indicate a new mechanism by which amyloid-beta can cause synaptic dysfunction and contribute to Alzheimer disease pathology.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alzheimer Disease / genetics
  • Alzheimer Disease / metabolism
  • Amyloid beta-Peptides / pharmacology
  • Amyloid beta-Peptides / physiology*
  • Amyloid beta-Protein Precursor / genetics
  • Animals
  • CREB-Binding Protein
  • Calcineurin / physiology
  • Cell Membrane / metabolism
  • Cerebral Cortex / metabolism
  • Disease Models, Animal
  • Electric Conductivity
  • Endocytosis / drug effects
  • Enzyme Activation / drug effects
  • Mice
  • N-Methylaspartate / pharmacology
  • Neurons / drug effects
  • Neurons / metabolism
  • Neurons / physiology
  • Nuclear Proteins / metabolism
  • Peptide Fragments / pharmacology
  • Protein Transport / physiology*
  • Protein Tyrosine Phosphatases / metabolism
  • Protein Tyrosine Phosphatases, Non-Receptor
  • Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors
  • Receptors, N-Methyl-D-Aspartate / metabolism*
  • Receptors, Nicotinic / physiology
  • Signal Transduction / drug effects
  • Synapses / metabolism
  • Trans-Activators / metabolism
  • alpha7 Nicotinic Acetylcholine Receptor

Substances

  • Amyloid beta-Peptides
  • Amyloid beta-Protein Precursor
  • Chrna7 protein, mouse
  • NR1 NMDA receptor
  • Nuclear Proteins
  • Peptide Fragments
  • Receptors, N-Methyl-D-Aspartate
  • Receptors, Nicotinic
  • Trans-Activators
  • alpha7 Nicotinic Acetylcholine Receptor
  • amyloid beta-protein (1-42)
  • N-Methylaspartate
  • CREB-Binding Protein
  • Crebbp protein, mouse
  • Calcineurin
  • Protein Tyrosine Phosphatases
  • Protein Tyrosine Phosphatases, Non-Receptor
  • Ptpn5 protein, mouse